Ji‐Xing Nan

4.0k total citations
122 papers, 3.4k citations indexed

About

Ji‐Xing Nan is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Ji‐Xing Nan has authored 122 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 46 papers in Molecular Biology and 40 papers in Hepatology. Recurrent topics in Ji‐Xing Nan's work include Liver Disease Diagnosis and Treatment (47 papers), Liver physiology and pathology (36 papers) and Drug-Induced Hepatotoxicity and Protection (22 papers). Ji‐Xing Nan is often cited by papers focused on Liver Disease Diagnosis and Treatment (47 papers), Liver physiology and pathology (36 papers) and Drug-Induced Hepatotoxicity and Protection (22 papers). Ji‐Xing Nan collaborates with scholars based in China, South Korea and Japan. Ji‐Xing Nan's co-authors include Yan‐Ling Wu, Li‐Hua Lian, Dong Hwan Sohn, Ting Bai, Eun‐Jeon Park, Ying Wan, Quan Jin, Jung Joon Lee, Ying‐Zi Jiang and Ben‐Wen Cui and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Ji‐Xing Nan

119 papers receiving 3.3k citations

Peers

Countries citing papers authored by Ji‐Xing Nan

Since Specialization

Citations

This map shows the geographic impact of Ji‐Xing Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Xing Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Xing Nan more than expected).

Fields of papers citing papers by Ji‐Xing Nan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Xing Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Xing Nan. The network helps show where Ji‐Xing Nan may publish in the future.

Co-authorship network of co-authors of Ji‐Xing Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Xing Nan. A scholar is included among the top collaborators of Ji‐Xing Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Xing Nan. Ji‐Xing Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thiazole isomers as potential ALK5 inhibitors alleviate P2X7R-mediated inflammation during liver fibrosis 2025 ·International Immunopharmacology ·Xueli Jiang, (unknown), (unknown), (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Cheng Hua Jin, Li‐Hua Lian	2
2	TLR3-mediated NET formation and macrophage activation in acute liver failure: Targeting IL-36 signaling to attenuate inflammatory drivers 2025 ·International Immunopharmacology ·Zhihong Zhang, Hongxu Yang, (unknown), Xueli Jiang, Siqi Wang, Yan‐Ling Wu, (unknown), Ji‐Xing Nan, Li‐Hua Lian	0
3	NETs contribute to psoriasiform skin inflammation: A novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside 2024 ·Phytomedicine ·(unknown), Min Jiang, Zhihong Zhang, (unknown), Xiangyuan Wang, Yan‐Ling Wu, Ji‐Xing Nan, Li‐Hua Lian	4
4	Astilbin alleviates hepatic fibrosis through PXR-PINK1/Parkin pathway: A new strategy by regulating hepatic stellate cells-macrophage crosstalk 2024 ·Phytomedicine ·(unknown), (unknown), (unknown), Jia Guo, (unknown), Li‐Hua Lian, Zhenyu Cui, Ji‐Xing Nan, Yan‐Ling Wu	8
5	Casting NETs on Psoriasis: The modulation of inflammatory feedback targeting IL-36/IL-36R axis 2024 ·International Immunopharmacology ·Zhihong Zhang, (unknown), Min Jiang, Xiangyuan Wang, (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Li‐Hua Lian	5
6	A therapeutic strategy of parthenolide in improving imiquimod-induced psoriasis-like skin inflammation targeting IL-36/NETs through skin transdermal therapeutic system 2024 ·International Immunopharmacology ·(unknown), Zhihong Zhang, (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Li‐Hua Lian	5
7	Raspberry Ketone Attenuates Hepatic Fibrogenesis and Inflammation via Regulating the Crosstalk of FXR and PGC-1α Signaling 2024 ·Journal of Agricultural and Food Chemistry ·(unknown), (unknown), (unknown), Chong Gao, (unknown), Li‐Hua Lian, Zhenyu Cui, Ji‐Xing Nan, Yan‐Ling Wu	6
8	Targeting RXFP1 by Ligustilide: A novel therapeutic approach for alcoholic hepatic steatosis 2023 ·International Immunopharmacology ·Hongxu Yang, Xueli Jiang, (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Li‐Hua Lian	6
9	Synthesis of and anti-fibrotic effect of pyrazole derivative J-1048: Inhibition of ALK5 as a novel approach to liver fibrosis targeting inflammation 2023 ·Bioorganic Chemistry ·Hongxu Yang, Fang-Yan Guo, (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Cheng Hua Jin, Li‐Hua Lian	12
10	Sesamol as a potential candidate for the treatment of hepatic fibrosis, based on its regulation of FXR/LXR axis-mediated inhibition of autophagy through crosstalk between hepatic cells and macrophage 2023 ·Phytomedicine ·Jun Chen, (unknown), Jiayi Dou, (unknown), Zhenyu Cui, Li‐Hua Lian, Ji‐Xing Nan, Yan‐Ling Wu	19
11	Stem Cell-Based Therapies for Inflammatory Bowel Disease 2022 ·International Journal of Molecular Sciences ·Huamin Zhang, Shuo Yuan, Huan Meng, (unknown), Jiao Li, (unknown), You Li, Qi Wang, Ji‐Xing Nan, Xuejun Jin, Qinggao Zhang	32
12	Allium victorialis L. Extracts Promote Activity of FXR to Ameliorate Alcoholic Liver Disease: Targeting Liver Lipid Deposition and Inflammation 2021 ·Frontiers in Pharmacology ·Zhenyu Cui, Xin Han, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yue Liu, Li‐Hua Lian, (unknown), Ji‐Xing Nan, Yan‐Ling Wu	16
13	Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway 2020 ·Journal of Ethnopharmacology ·(unknown), Yan‐Ling Wu, Xiuzhi Wang, Shuying Han, Sungbo Cho, Wuliji Ao, Ji‐Xing Nan	48
14	Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells 2013 ·International Immunopharmacology ·Ting Bai, Li‐Hua Lian, Yan‐Ling Wu, Ying Wan, Ji‐Xing Nan	102
15	The protective effects of total saponins from Ornithogalum saundersiae (Liliaceae) on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice 2010 ·Journal of Ethnopharmacology ·(unknown), Yan‐Ling Wu, (unknown), Li‐Hua Lian, Ying‐Zi Jiang, Ji‐Xing Nan	25
16	Hepatoprotective effects of salidroside on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice 2009 ·Journal of Pharmacy and Pharmacology ·Yan‐Ling Wu, Li‐Hua Lian, Ying‐Zi Jiang, Ji‐Xing Nan	47
17	Protective effects of chalcone derivatives for acute liver injury in mice 2005 ·Archives of Pharmacal Research ·Liping Guan, Ji‐Xing Nan, Xuejun Jin, (unknown), (unknown), Kyu‐Yun Chai, Zhe‐Shan Quan	18
18	Effect of Acanthopanax koreanum Nakai (Araliaceae) on d-galactosamine and lipopolysaccharide-induced fulminant hepatitis 2004 ·Journal of Ethnopharmacology ·Ji‐Xing Nan, Eun‐Jeon Park, (unknown), Yuzhe Zhao, Xing Fu Cai, Young Ho Kim, Dong Hwan Sohn, Jung-Joon Lee	33
19	Antifibrotic Effects of the Methanol Extract of Polygonum aviculare in Fibrotic Rats Induced by Bile Duct Ligation and Scission. 2000 ·Biological and Pharmaceutical Bulletin ·Ji‐Xing Nan, Eun‐Jeon Park, (unknown), Geonil Ko, Dong Hwan Sohn	26
20	Antifibrotic effect ofStephania tetrandra on experimental liver fibrosis induced by bile duct ligation and scission in rats 2000 ·Archives of Pharmacal Research ·Ji‐Xing Nan, (unknown), Sung Hee Lee, (unknown), (unknown), Geonil Ko, Dong Hwan Sohn	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact